Back to Search
Start Over
Glucagon-like peptide (GLP)-1 and the synthetic analogue exenatide: From novel therapy for diabetes to growth inhibition of breast cancer cells
- Source :
- Journal of Clinical Oncology. 28:e21035-e21035
- Publication Year :
- 2010
- Publisher :
- American Society of Clinical Oncology (ASCO), 2010.
-
Abstract
- e21035 Background: GLP-1 is a hormone secreted from endocrine L cells in the gut in response to food intake and promotes insulin secretion and satiety. These activities indicated GLP-1 as a potenti...
- Subjects :
- chemistry.chemical_classification
endocrine system
Cancer Research
medicine.medical_specialty
business.industry
digestive, oral, and skin physiology
Peptide
medicine.disease
Glucagon
Synthetic analogue
chemistry.chemical_compound
Endocrinology
Oncology
chemistry
Diabetes mellitus
Internal medicine
medicine
Endocrine system
Breast cancer cells
Growth inhibition
business
Exenatide
hormones, hormone substitutes, and hormone antagonists
medicine.drug
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 28
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........b3b1cd7928a816417d0a8da1a54d859b
- Full Text :
- https://doi.org/10.1200/jco.2010.28.15_suppl.e21035